The FDA is seeking to further understand topics related to evaluating the safety and efficacy of the drug, including results in patients who have taken it and the efficacy implications of the trial design.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Discussion about this post